# EDGAR Filing Document

**Accession Number:** 0001757539
**File Stem:** 0001193125-26-039466
**Filing Date:** 2026-2
**Character Count:** 17303
**Document Hash:** 3b5d276703a06177bc222f2c0a4a0ca8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-039466.hdr.sgml**: 20260205

**ACCESSION NUMBER**: 0001193125-26-039466

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260205

**FILED AS OF DATE**: 20260205

**DATE AS OF CHANGE**: 20260205

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Nielsen Kirk G.
- **CENTRAL INDEX KEY:** 0001523522

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43105
- **FILM NUMBER:** 26603258

**BUSINESS ADDRESS:**
- **BUSINESS PHONE:** 650-233-7877

**MAIL ADDRESS:**
- **STREET 1:** ONE SANSOME STREET
- **STREET 2:** SUITE 3630
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94104
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Klein Peter Justin
- **CENTRAL INDEX KEY:** 0001608710

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43105
- **FILM NUMBER:** 26603257

**MAIL ADDRESS:**
- **STREET 1:** 5425 WISCONSIN AVE
- **CITY:** CHEVY CHASE
- **STATE:** MD
- **ZIP:** 20815
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Vensana Capital I GP, LLC
- **CENTRAL INDEX KEY:** 0001854073

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43105
- **FILM NUMBER:** 26603260

**BUSINESS ADDRESS:**
- **STREET 1:** 3601 W 76TH ST
- **STREET 2:** SUITE 20
- **CITY:** MINNEAPOLIS
- **STATE:** MN
- **ZIP:** 55435
- **BUSINESS PHONE:** 650-843-5000

**MAIL ADDRESS:**
- **STREET 1:** 3601 W 76TH ST
- **STREET 2:** SUITE 20
- **CITY:** MINNEAPOLIS
- **STATE:** MN
- **ZIP:** 55435
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Vensana Capital I, L.P.
- **CENTRAL INDEX KEY:** 0001757539

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43105
- **FILM NUMBER:** 26603259

**BUSINESS ADDRESS:**
- **STREET 1:** 3601 W 76TH STREET
- **STREET 2:** SUITE 20
- **CITY:** MINNEAPOLIS
- **STATE:** MN
- **ZIP:** 55344
- **BUSINESS PHONE:** (650) 843-5000

**MAIL ADDRESS:**
- **STREET 1:** 3601 W 76TH STREET
- **STREET 2:** SUITE 20
- **CITY:** MINNEAPOLIS
- **STATE:** MN
- **ZIP:** 55344

**FORMER NAME:**
- **FORMER CONFORMED NAME:** VMT Fund I, L.P.
- **DATE OF NAME CHANGE:** 20181116

**FORMER NAME:**
- **FORMER CONFORMED NAME:** VMT I, L.P.
- **DATE OF NAME CHANGE:** 20181030
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SpyGlass Pharma, Inc.
- **CENTRAL INDEX KEY:** 0001778922
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 833044245
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 27081 ALISO CREEK ROAD
- **STREET 2:** SUITE 125
- **CITY:** ALISO VIEJO
- **STATE:** CA
- **ZIP:** 92656
- **BUSINESS PHONE:** 949-284-6904

**MAIL ADDRESS:**
- **STREET 1:** 27081 ALISO CREEK ROAD
- **STREET 2:** SUITE 125
- **CITY:** ALISO VIEJO
- **STATE:** CA
- **ZIP:** 92656

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SpyGlassPharma, Inc.
- **DATE OF NAME CHANGE:** 20230711

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SpyGlass Ophthalmics, Inc.
- **DATE OF NAME CHANGE:** 20190605

## Exhibit 24.1

**Exhibit 24.1**

**<u>POWER OF ATTORNEY</u>**

March 18, 2021

Each of the undersigned, including (i) Vensana Capital I GP, LLC, a Delaware limited liability company (the "***Fund I GP***"), in the normal course of its business and in its capacity as the general partner of Vensana Capital I, L.P., (ii) Vensana Capital Management, LLC, a Delaware limited liability company (the "***Management Company***") and (iii) each of Kirk Nielsen and Peter Justin Klein (the ***"Managing Directors***") in their respective capacities as the managing directors of the General Partner and the Management Company, hereby constitutes and approves STEVEN SCHWEN (the "***Attorney-in-Fact***") as the undersigned's true and lawful attorney-in-fact to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Execute for and on behalf of the undersigned any and all documents, agreements, filings, reports, consents, waivers, certificates, forms, proxies, notices or communications, or amendments or modifications to any of the foregoing, requested by the undersigned in connection with the conduct of the undersigned's business (collectively, the "***Documents***");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any and all such Documents;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Execute for and on behalf of each of the undersigned (a "***Reporting Person***") any and all reports, notices, communications and other documents (including, but not limited to, reports on Schedule 13D, Schedule 13F, Schedule 13G, Form 13H, Form 13-F, Form 3, Form 4 and Form 5) that such Reporting Person may be required to file with the United States Securities and Exchange Commission pursuant to the U.S. Securities Act of 1933, as amended, and the U.S. Securities Exchange Act of 1934, as amended (collectively, the "***Reports***") with respect to each Reporting Person's (a) status as an officer or director of, or (b) ownership of, or transactions in, securities of, any entity whose securities are beneficially owned (directly or indirectly) by the applicable Reporting Person;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) Do and perform any and all acts for and on behalf of each of the undersigned which may be necessary or desirable to complete and execute any such Reports and timely file such forms and schedules with the United States Securities and Exchange Commission and any other stock exchange or similar authority; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) Take any other action of any type whatsoever in connection with the foregoing which, in the opinion of the Attorney-in-Fact, may be of benefit to, in the best interest of, or legally required by, each of the undersigned, it being understood that the documents executed by the Attorney-in- Fact on behalf of the undersigned, pursuant to this Power of Attorney, shall be in such form and shall contain such terms and conditions as the Attorney-in-Fact may approve in his discretion.

In exercising the powers granted herein, the Attorney-in-Fact may execute any and all Documents and Reports (i) on behalf of the Fund I GP or Management Company as "Chief Financial Officer" (or "CFO") or (ii) on behalf of any of the undersigned as an "Authorized Person", "Authorized Signatory" or "Attorney-in-Fact."

Each of the undersigned hereby grants to the Attorney-in-Fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary, and proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that the Attorney- in-Fact, or his substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted.

Each Reporting Person acknowledges that the Attorney-in-Fact, in serving in such capacity at the request of each such Reporting Person, is in no way hereby assuming, nor is any other Reporting Person hereby assuming, any of each such Reporting Person's responsibilities under the laws of the United States or any state, including without limitation, compliance with Section 16 or Section 13 of the U.S. Securities Exchange Act of 1934, as amended.

This Power of Attorney granted to the Attorney-in-Fact replaces in full that certain Power of Attorney executed by the Fund I GP and the Management Company with respect to the Attorney-in-Fact as of February 11, 2021 and shall remain in full force and effect with respect to each of the undersigned until (x) the Attorney-in-Fact is no longer employed by or otherwise serving as Chief Financial Officer of the Management Company, or (y) a Reporting Person earlier revokes this Power of Attorney with respect to such Reporting Person by delivering written notice of such revocation to the Attorney-in- Fact.

*[Signature pages follow.]*

------

IN WITNESS WHEREOF, each of the undersigned has caused this Power of Attorney to be executed effective as of the date first set forth above.

---

| | |
|:---|:---|
| VENSANA CAPITAL I GP, LLC | VENSANA CAPITAL I GP, LLC |
| By: | /s/ Peter Justin Klein |
| Name: | Peter Justin Klein  |
| Title: | Managing Director |
| By: | /s/ Kirk Nielsen |
| Name: | Kirk Nielsen |
| Title: | Managing Director |
| VENSANA CAPITAL MANAGEMENT, LLC | VENSANA CAPITAL MANAGEMENT, LLC |
| By: | /s/ Peter Justin Klein |
| Name: | Peter Justin Klein |
| Title: | Manager Director |
| By: | /s/ Kirk Nielsen |
| Name: | Kirk Nielsen |
| Title: | Manager Director |
| /s/ Kirk Nielsen | /s/ Kirk Nielsen |
| Kirk Nielsen | Kirk Nielsen |
| /s/ Peter Justin Klein  | /s/ Peter Justin Klein  |
| Peter Justin Klein | Peter Justin Klein |

---

------

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Vensana Capital I GP, LLC<br><sub>(Last) (First) (Middle)</sub><br>3601 W. 76TH STREET, SUITE 20<br><sub>(Street)</sub><br>EDINA, MN 55435<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>SpyGlass Pharma, Inc. [ SPG ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-02-05 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [X] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Vensana Capital I, L.P.<br><sub>(Last) (First) (Middle)</sub><br>3601 W. 76TH STREET<br>SUITE 20<br><sub>(Street)</sub><br>EDINA, MN 55435<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>SpyGlass Pharma, Inc. [ SPG ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-02-05 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [X] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Nielsen Kirk G.<br><sub>(Last) (First) (Middle)</sub><br>3601 W. 76TH STREET<br>SUITE 20<br><sub>(Street)</sub><br>EDINA, MN 55435<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>SpyGlass Pharma, Inc. [ SPG ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-02-05 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [X] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Klein Peter Justin<br><sub>(Last) (First) (Middle)</sub><br>3601 W. 76TH STREET<br>SUITE 20<br><sub>(Street)</sub><br>EDINA, MN 55435<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>SpyGlass Pharma, Inc. [ SPG ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-02-05 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [X] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Series B Preferred Stock | <sup>(1)</sup> | <sup>(1)</sup> | Common Stock | 1690230 | <sup>(1)</sup> | I | See Footnote<sup>(2)</sup> |
| Series C-1 Preferred Stock | <sup>(1)</sup> | <sup>(1)</sup> | Common Stock | 548067 | <sup>(1)</sup> | I | See Footnote<sup>(2)</sup> |
| Series C-2 Preferred Stock | <sup>(1)</sup> | <sup>(1)</sup> | Common Stock | 548067 | <sup>(1)</sup> | I | See Footnote<sup>(2)</sup> |
| Series D Preferred Stock | <sup>(1)</sup> | <sup>(1)</sup> | Common Stock | 359255 | <sup>(1)</sup> | I | See Footnote<sup>(2)</sup> |

---

### Footnotes:

(1) All shares of the preferred stock, par value $0.00001 per share, of the Issuer will automatically be converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock") prior to the closing of the Issuer's initial public offering of its Common Stock.

(2) These shares are held directly by Vensana Capital I, L.P. ("Vensana I"). Vensana Capital I GP, LLC ("Vensana GP I") is the general partner of Vensana I. Kirk Nielsen, a member of the Issuer's board of directors, and Peter Justin Klein (the "GP I Managing Directors") are the managing directors of Vensana GP I. Each of Vensana GP I and the GP I Managing Directors, in their capacities with respect to Vensana GP I, may be deemed to have voting, investment and dispositive power with respect to the shares held by Vensana I. Each of Vensana GP I and the GP I Managing Directors disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of Vensana GP I or the GP I Managing Directors is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.

**Remarks:**
Exhibit 24 - Power of Attorney

**Signature:** /s/ Steven Schwen, Chief Financial Officer of Vensana Capital I GP, LLC  
**Date:** 2026-02-05

**Signature:** /s/ Steven Schwen, Chief Financial Officer of Vensana Capital I GP, LLC, the general partner of Vensana Capital I, L.P.  
**Date:** 2026-02-05

**Signature:** /s/ Steven Schwen, as attorney-in-fact for Kirk Nielsen  
**Date:** 2026-02-05

**Signature:** /s/ Steven Schwen, as attorney-in-fact for Peter Justin Klein  
**Date:** 2026-02-05

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**